PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy

BACKGROUND: Pancreatic adenocarcinoma (PAAD) is an aggressive solid tumour characterised by few early symptoms, high mortality, and lack of effective treatment. Therefore, it is important to identify new potential therapeutic targets and prognostic biomarkers of PAAD. METHODS: The Cancer Genome Atla...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xingyi, Yi, Xiaoyu, Zou, Xiaocui, Chen, Yuan, Tai, Yanhong, Ren, Xuhong, He, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642060/
https://www.ncbi.nlm.nih.gov/pubmed/37957639
http://dx.doi.org/10.1186/s12885-023-11474-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642060/
https://www.ncbi.nlm.nih.gov/pubmed/37957639
http://dx.doi.org/10.1186/s12885-023-11474-1

Ejemplares similares